Royal Bank Of Canada Issues Positive Forecast for Ardent Health (NYSE:ARDT) Stock Price

Ardent Health (NYSE:ARDT) had its price target raised by Royal Bank Of Canada from $13.00 to $18.00 in a research report report published on Friday,Benzinga reports. The firm currently has an outperform rating on the stock.

ARDT has been the topic of several other reports. Truist Financial lifted their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, August 6th. BMO Capital Markets initiated coverage on Ardent Health in a report on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 target price for the company. Leerink Partners reaffirmed an “outperform” rating and set a $14.00 target price on shares of Ardent Health in a research report on Friday, September 18th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Finally, Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $13.54.

Ardent Health Stock Up 8.3%

NYSE ARDT traded up $1.32 during trading on Friday, reaching $17.23. 3,465,561 shares of the company’s stock traded hands, compared to its average volume of 486,889. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The firm has a market cap of $2.43 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 3.32 and a beta of 0.58. The company’s 50 day simple moving average is $11.44 and its two-hundred day simple moving average is $10.10. Ardent Health has a 12-month low of $7.71 and a 12-month high of $17.67.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.23 by $0.08. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.60 billion. As a group, sell-side analysts forecast that Ardent Health will post 0.96 EPS for the current fiscal year.

Institutional Trading of Ardent Health

Institutional investors have recently modified their holdings of the company. Allworth Financial LP purchased a new position in shares of Ardent Health in the 2nd quarter worth approximately $28,000. Integrated Wealth Concepts LLC purchased a new stake in Ardent Health during the second quarter valued at approximately $57,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Ardent Health during the third quarter valued at approximately $61,000. Abel Hall LLC purchased a new stake in Ardent Health during the first quarter valued at approximately $87,000. Finally, Brighton Jones LLC acquired a new stake in Ardent Health in the third quarter valued at approximately $110,000.

More Ardent Health News

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Ardent reported Q3 earnings of $0.31 per share, ahead of analyst estimates of roughly $0.23–$0.24, and revenue of $1.625 billion versus the $1.60 billion consensus. Recent coverage also highlighted a return to profitability and improved guidance. Zacks Q3 earnings report Profit and guidance coverage
• Positive Sentiment: Stephens raised its price target to $21 from $13 and maintained an Overweight rating, implying further potential upside from the quoted $17.23 share price. Stephens ratings
• Positive Sentiment: RBC lifted its target to $18 from $13 and reiterated an Outperform rating, signaling a more positive view after the results. RBC ratings
• Neutral Sentiment: The strong rally has brought the stock close to its 12-month high, and a recent analysis questioned whether shares may already be above fair value. That could limit further gains if investors have priced in the earnings beat and raised outlook. Valuation analysis
• Negative Sentiment: Despite beating estimates, quarterly EPS was below the $0.52 reported a year earlier, pointing to year-over-year earnings pressure. Zacks earnings comparison

Ardent Health Company Profile

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.